Underfunding Research Of Female Health Leaves Huge Amounts Of Money On The Table

Posted May 12, 2022 from medicalfuturist.com

Under-researched female health problems have incredible societal costs. Not only on the labour market, but also in other areas. 

But there is a long list of diseases and conditions that have a significantly higher prevalence among one of the sexes, like liver cancer or tuberculosis occurring more often in the male population, and autoimmune diseases or multiple sclerosis among the females. The interesting thing is, that figures suggest that although roughly half the population is female pretty much all across the globe, research on female-dominant diseases is underfunded, while male-dominant ones are overfunded. Endometriosis, Alzheimer’s, Crohn disease, rheumatoid arthritis and autoimmune conditions are just a few of the diseases that are affecting women significantly more and receive only a moderate amount of research funding. Females were not included in clinical trials before 1993, not even in mice The fact that women generally experience significantly more side effects from various drugs is not surprising after knowing how they were not included in clinical trials for quite a long time.

Female Founders #womenshealth

Facebook Share

Twitter Share

Linkedin Share

Email Share

See Topics

• Medigy: Female Founders
• Symplur: #womenshealth

See Also

• How Can We Reduce Clinician Burnout? Improving Patient and Caregiver Engagement
• Hospitals' per patient labor spend increased 37% from 2019 to Q1 2022
• Actionable Intelligence Network presents The Summit on Embedding Privacy in Digital Health: Medical Devices, IoMTs & Wearables, a virtual event to be held on May 25-26, 2022
• Best Practices for Identifying Claim Errors Prepayment
• Intermountain Partners with VC Firm General Catalyst on Innovation